ubmslateCN-logo-ubm

CN Mobile Logo

Topics:

Lung Cancer

Older Early-Stage NSCLC Patients Benefit From Adjuvant Chemotherapy

Early-stage non–small-cell lung cancer patients over 70 years old derive a similar benefit as younger patients from adjuvant chemotherapy following surgical resection. Image © pruit phatsrivong / Shutterstock.com.

Lung Cancer

© Volodymyr Baleha/Shutterstock.com

Infections with pneumonia send a substantial number of older adults to the hospital, much more than younger adults. Researchers are calling for new rapid diagnostic tests.

Six carbonyl compounds in exhaled breath can effectively discriminate between lung cancer patients and healthy patients, says a new study.

Adding tivantinib to erlotinib improved progression-free survival but not overall survival in patients with previously treated non-small-cell lung cancer.

Recent progress in lung cancer was a bright spot at the 2015 ASCO Annual Meeting. Several studies were presented that either are practice-changing or will likely lead to practice changes in the future.

Oncologists now have a newly approved first-line treatment for patients with metastatic non-small cell lung cancer (NSCLC).

The use of CT-guided radiofrequency ablation is well tolerated and effective among patients with inoperable stage IA non-small-cell lung cancer.

Use of post-operative radiotherapy was associated with better overall survival in patients with incompletely resected stage II/III non-small-cell lung cancer.

Pages

Subscribe to Lung Cancer on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.